Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
CRH
CRH
|
+$1.93B |
| 2 |
Texas Instruments
TXN
|
+$1.78B |
| 3 |
NVIDIA
NVDA
|
+$1.66B |
| 4 |
Starbucks
SBUX
|
+$1.15B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$974M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.13B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.32B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.13B |
| 5 |
Procter & Gamble
PG
|
+$923M |
Sector Composition
| 1 | Technology | 33.53% |
| 2 | Consumer Discretionary | 10.88% |
| 3 | Financials | 10.79% |
| 4 | Communication Services | 9.25% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Virginia National Bankshares
VABK
$220M
| $53K | ﹤0.01% |
1,627
-1,671
| -51% | -$54.4K |
|
3502
Arq
ARQ
$310M
| $53K | ﹤0.01% |
+8,619
| New | +$53K |
|
|
ONIT
3503
Onity Group Inc.
ONIT
$349M
| $53K | ﹤0.01% |
2,202
-2,351
| -52% | -$56.6K |
|
|
GTHX
3504
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $53K | ﹤0.01% |
23,032
+16,730
| +265% | +$38.5K |
|
3505
Acumen Pharmaceuticals
ABOS
$87.2M
| $52K | ﹤0.01% |
21,446
-25,864
| -55% | -$62.7K |
|
3506
BigBear.ai
BBAI
$1.78B
| $52K | ﹤0.01% |
34,552
-1,577
| -4% | -$2.37K |
|
3507
Cibus
CBUS
$68.3M
| $52K | ﹤0.01% |
5,235
-12,765
| -71% | -$127K |
|
3508
Escalade
ESCA
$173M
| $52K | ﹤0.01% |
3,753
-3,404
| -48% | -$47.2K |
|
3509
Fennec Pharmaceuticals
FENC
$251M
| $52K | ﹤0.01% |
8,368
-4,508
| -35% | -$28K |
|
|
FSP
3510
Franklin Street Properties
FSP
$175M
| $52K | ﹤0.01% |
33,984
-68,723
| -67% | -$105K |
|
3511
LiveWire
LVWR
$915M
| $52K | ﹤0.01% |
6,736
-7,185
| -52% | -$55.5K |
|
3512
VanEck Morningstar Wide Moat ETF
MOAT
$12.7B
| $52K | ﹤0.01% |
606
| – | – |
|
3513
Personalis
PSNL
$472M
| $52K | ﹤0.01% |
45,024
| – | – |
|
|
FFNW
3514
DELISTED
First Financial Northwest, Inc
FFNW
| $52K | ﹤0.01% |
+2,451
| New | +$52K |
|
3515
Cerence
CRNC
$418M
| $51K | ﹤0.01% |
18,129
-31,168
| -63% | -$87.7K |
|
|
IMAB
3516
I-MAB
IMAB
$376M
| $51K | ﹤0.01% |
30,370
-8,182
| -21% | -$13.7K |
|
3517
Inhibrx
INBX
$422M
| $51K | ﹤0.01% |
+3,579
| New | +$51K |
|
3518
Lineage Cell Therapeutics
LCTX
$290M
| $51K | ﹤0.01% |
51,376
-42,551
| -45% | -$42.2K |
|
3519
Medallion Financial
MFIN
$250M
| $51K | ﹤0.01% |
6,555
-17,380
| -73% | -$135K |
|
|
NEXN
3520
Nexxen International
NEXN
$639M
| $51K | ﹤0.01% |
9,000
| – | – |
|
3521
Tootsie Roll Industries
TR
$3B
| $51K | ﹤0.01% |
1,752
-1,565
| -47% | -$45.6K |
|
3522
Ventyx Biosciences
VTYX
$170M
| $51K | ﹤0.01% |
21,519
-11,487
| -35% | -$27.2K |
|
3523
Alto Ingredients
ALTO
$88.2M
| $50K | ﹤0.01% |
34,253
-85,379
| -71% | -$125K |
|
3524
Bel Fuse Class A
BELFA
$1.48B
| $50K | ﹤0.01% |
610
-5,464
| -90% | -$448K |
|
3525
GoHealth
GOCO
$75.8M
| $50K | ﹤0.01% |
5,208
-1,325
| -20% | -$12.7K |
|